[Fatal pulmonary embolism in venous thrombosis of the leg and pelvis during lysis therapy].
A 19-year-old girl had for four weeks the clinical signs of recurrent pulmonary emboli and deep-vein thrombosis (tachycardia, dyspnoea, right inguinal pain), which had been misdiagnosed. The correct diagnosis was made only after drastic deterioration in her condition following appendicectomy for falsely diagnosed appendicitis. Urokinase infusion (80,000-160,000 IU/h for 11 days) having failed to bring about improvement, much greater than ultra-high much less than thrombolysis with streptokinase was begun (250,000 IU streptokinase over 30 min, followed by 9 million IU over 6 hours). Fatal pulmonary embolism occurred seven hours after the end of the infusion. Autopsy revealed extensive separation of thrombotic material in the pelvic veins. This observation and other reports should serve as a warning against using streptokinase in ultra-high doses if large veins, as those in the pelvis, are involved.
Grimm
W
W
Klinik für Innere Medizin, Medizinische Universität Lübeck.
Schwieder
G
G
Wagner
T
T
D000328:Adult; D003951:Diagnostic Errors; D005260:Female; D005268:Femoral Vein; D006801:Humans; D007084:Iliac Vein; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D012008:Recurrence; D013300:Streptokinase / Q000008:administration & dosage*; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*; D014682:Vena Cava, Inferior
D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
Tödliche Lungenembolie bei Bein-Beckenvenenthrombose unter Lysetherapie.